None listed
Conditions
Interventions
Intervention1: Mw Injection: 0.1 ml would be given to healthy Subjects on Day 1 AND IF required Day 16
Control Intervention1: Distilled water: 0.1 ml would be given on day 1 and 16
Sponsors
SGT University
Eligibility
Inclusion criteria
Inclusion criteria: 1.Healthy subjects of either gender, age >= 18 years. 2.Female subject who are currently using reliable methods of contraception (barrier methods and intrauterine contraceptive device), with a negative urine pregnancy test during screening and agree to informed compliance of contraceptive method until at least months post-dosing. 3.The subject must be able and willing to comply with the study protocol, available and willing to complete all the study assessments and must have signed an Informed Consent Form.
Exclusion criteria
Exclusion criteria: 1. Any febrile illness with oral temperature > 100°F within 3 days prior to randomization. 2. Subject with past history of COVID-19 infection. 3. Pregnant and / or lactating female subjects. 4. Presence of any illness requiring hospital referral. 5. Any confirmed or suspected immune-deficient condition based on medical history and physical examination and a family history of congenital or hereditary immunodeficiency or Individuals on immunosuppressant's as Azathioprine, Cyclosporine, Mycophenolate etc. 6. History of allergic reactions or anaphylaxis to Mw or its component.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the incidence of RT-PCR proved COVID-19 in Mw treated group in comparison to control group.Timepoint: 6 month | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate the rates of hospitalization, Severity of illness/Days of hospitalization, and To evaluate the safety of mycobacterium w Timepoint: 6 month | — |
Countries
India
Contacts
Public ContactNarinder Pal Singh
SGTUniversity
Outcome results
None listed